Inequitable access to HIV drugs in Canada
CHÉOS Director Dr. Aslam Anis was quoted in a story in Global News about a study which found that the risk of transmitting HIV to a sexual partner is completely erased in people on effective antiretroviral therapy (ART) regimens. Dr. Anis provided commentary on the price of ART drugs in Canada, the lack of universal coverage for these medications, and the ongoing issues related to access to testing and treatment.
Foundry’s unique approach to youth mental health
Dr. Skye Barbic was interviewed in a story that appeared in Spark, the Michael Smith Foundation for Health Research (MSFHR) digital publication. The story describes the launch and development of Foundry and the unique approach that the seven Foundry centres take to providing and researching mental health services for youth in B.C. Dr. Barbic is a 2018 MSFHR Scholar.
Addressing B.C.’s family doctor shortage
CHÉOS Scientist Dr. Rita McCracken was interviewed on CBC News about potential solutions to the shortage of family physicians in Canada. In B.C., about 1 in 6 residents is unable to find a family physician. Potential solutions discussed included modification of payment structures and development of team-based care models.
Reducing chronic disease through sugar reduction strategies
An editorial authored by CHÉOS’ Dr. Annalijn Conklin was quoted in a story about research on the UK government’s efforts to reduce dietary sugar consumption. Dr. Conklin’s editorial stressed the need for a multi-pronged approach to improving diet if we are to successfully reduce the burden of nutrition-related chronic diseases.
The potential perils of generic drugs
In an excerpt from a book about the generic drug industry, an article in TIME discussed the experiences of Dr. Brian Westerberg during his volunteer missions to Kampala, Uganda. In some cases, Dr. Westerberg found that some generic drug treatments contained significantly less of the active ingredient than their labels claimed, making them unsafe and ineffective, discussed in a 2016 case report in the CDC Morbidity and Mortality Weekly Report (MMWR).
Why are C-section rates still climbing?
CHÉOS Scientist Dr. Sarah Munro spoke with Global News about a report released by the Canadian Institute for Health Information (CIHI). The report found that C-section was the top reason for surgery in Canada in 2017/18, performed in nearly 30 per cent of births. Dr. Munro was interviewed about the increasing rates of C-section across the country. Watch the interview here or listen to a longer version via podcast.
Steroids made reduce lung cancer in COPD
The findings of a new study led by CHÉOS Scientist Dr. Larry Lynd were covered in news stories appearing The Vancouver Sun, The Province, UBC News, EurekAlert!, OnMedica, Business Standard, and The Daily Scan.The study, published in the European Respiratory Journal, shows that the daily use of a steroid inhaler may reduce COPD patients’ risk of lung cancer by as much as 30 per cent.